Pharmaceutical preparations company · DE · FY ends Dec · Revenue $61M · 22.08% margin · $7M FCF
Operating margin is thin at 9.45%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue up 39.2% YoY with margins expanding 162.4pp.
Negative free cash flow of -$13M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$61M
▲ +39.2% YoY
Net Income (TTM)
$15M
▲ +112.5% YoY
Op. Margin
22.08%
▲ +162.4pp YoY
ROIC
23.25%
▲ +81.9pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$7M
▲ +46.2% YoY
Op. Cash Flow (TTM)
$7M
▲ +46.2% YoY
Net Debt
-$54M
Net Cash Position
Cash & Equiv.
$56M
5Y CAGR: +48.2%
Continue Research